In addition, in one of them, the results indicated that this correlation is independent of KRAS status, but that there is an increase in expression of some proteins of the TMEJ pathway in pancreatic cancer cells, both in tumor samples and in cell lines carrying the activating KRAS mutation G12D (22). The gene discussed is KRAS; the disease is pancreatic neoplasm.